| case report | Q2782326 |
| scholarly article | Q13442814 |
| P50 | author | Natee Sirinvaravong | Q89438076 |
| P2093 | author name string | Alexander Rubin | |
| Soumya Patnaik | |||
| Mahek Shah | |||
| Gustavo Fernandez | |||
| Jose-Nitram Aliling | |||
| Mary C Rodriguez Ziccardi | |||
| P2860 | cites work | Surgical treatment of nonbacterial thrombotic endocarditis presenting with stroke | Q81430019 |
| A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) | Q28174751 | ||
| A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome | Q28193536 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses | Q29542806 | ||
| Libman-Sacks endocarditis and embolic cerebrovascular disease. | Q30573314 | ||
| The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study | Q30885847 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review | Q33414398 | ||
| Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features | Q33493746 | ||
| Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome | Q33495531 | ||
| Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies | Q33937799 | ||
| Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. | Q33956621 | ||
| Antiphospholipid antibody-associated non-infective mitral valve endocarditis successfully treated with medical therapy | Q34036446 | ||
| Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics | Q35147247 | ||
| Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report | Q35189299 | ||
| Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome | Q35554870 | ||
| Non-bacterial thrombotic endocarditis | Q36946266 | ||
| Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis | Q36964664 | ||
| Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial | Q37230504 | ||
| Stroke and a valvular lesion in a patient with stage IV non-small cell lung cancer | Q38849747 | ||
| Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature | Q38998378 | ||
| Nonbacterial thrombotic endocarditis: a review | Q39760209 | ||
| Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: A single-center experience | Q39907682 | ||
| Clinical course of high-risk patients diagnosed with antiphospholipid syndrome | Q39934417 | ||
| The diagnosis and treatment of stroke in a patient with cancer: nonbacterial thrombotic endocarditis (NBTE): a case report and review | Q40810107 | ||
| Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. | Q41939439 | ||
| Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis. | Q42750309 | ||
| Catastrophic antiphospholipid syndrome: a case series | Q43409543 | ||
| A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome | Q44588720 | ||
| Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation | Q48197641 | ||
| Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves | Q71523917 | ||
| Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome | Q81055584 | ||
| Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease | Q81074680 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P304 | page(s) | omy024 | |
| P577 | publication date | 2018-06-25 | |
| P1433 | published in | Oxford medical case reports | Q27726099 |
| P1476 | title | Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome | |
| P478 | volume | 2018 |
| Q64262888 | Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form | cites work | P2860 |
Search more.